Genetic Engineering and the World Trade System

While the WTO agreements do not regulate the use of biotechnology per se, their rules can have a profound impact on the use of the technology for both commercial and non-commercial purposes. This book seeks to identify the challenges to international trade regulation that arise from biotechnology. The contributions examine whether existing international obligations of WTO Members are appropriate to deal with the issues arising for the use of biotechnology and whether there is a need for new international legal instruments, including a potential WTO Agreement on Biotechnology. They combine various perspectives on and topics relating to genetic engineering and trade, including human rights and gender; intellectual property rights; traditional knowledge and access and benefit sharing; food security, trade and agricultural production and food safety; and medical research, cloning and international trade.

Author Biography

Daniel Wuger is a lecturer at the University of Bern, a senior research fellow at the Swiss Federal Office of Justice and a consultant to the NCCR International Trade Regulation project at the World Trade Institute, Bern. Thomas Cottier is Professor of European and International Economics Law at the University of Bern and Director of the Institute of European and International Economic Law. He is also Managing Director of the World Trade Institute.